Search This Blog

Monday, December 2, 2013

Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation (NYSE:LLY)

Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.